NCT02473887View on ClinicalTrials.gov

Flavored Intravenous Ondansetron Administered Orally for the Treatment of Persistent Vomiting

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions

Gastroenteritis

Interventions

DRUG

Ondansetron with1:1 ORA - sweet.

single dose of intravenous ondansetron form orally after being flavored with 1:1 ORA-sweet, the dose of ondansetron was determined based on the patient presenting weight.